Exhibit 107.1

Calculation of Filing Fee Tables

FORM S-8

(Form Type)

Gyre Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

Security Type	Security Class Title⁽¹⁾	Fee Calculation Rule⁽²⁾	Amount Registered⁽³⁾	Proposed Maximum Offering Price Per Unit	Maximum Aggregate Offering Price	Fee Rate	Amount of Registration Fee
Equity	Common stock, par value $0.001 per share	Rule 457(a)	3,829,780	$17.05	$65,297,749	$147.60 per $1,000,000	$9,637.95
Total Offering Amounts					$65,297,749		$9,637.95
Total Fee Offsets							—
Net Fee Due							$9,637.95

(1)

Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement on Form S-8 shall also cover such indeterminate number of additional shares of common stock, par value $0.001 per share (the “Common Stock”) of Gyre Therapeutics, Inc. as may become issuable to prevent dilution in the event of stock splits, stock dividends or similar transactions pursuant to the terms of the Gyre Therapeutics, Inc. 2023 Omnibus Incentive Plan (the “Plan”).

(2)

Calculated solely for the purpose of determining the registration fee pursuant to Rules 457(c) and (h) of the Securities Act, and based on the average of the high and low sale prices of the Common Stock, as quoted on The Nasdaq Capital Market on March 25, 2024.

(3)

Represents 3,829,780 shares of Common Stock reserved for issuance under the Plan.